AIHC Capital Management Ltd

CENTRAL, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$108.7M2026 Q3
Positions6
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

AIHC Capital Management Ltd reported 6 positions worth $108.7M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ORIC (57.4%).

6 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ORICOric Pharmaceuticals$62.4M57.39%4,630,986——-44.2%
▸ 2 LEGNLegend Biotech$23.5M21.64%1,182,389——-12.0%
▸ 3 RVMDRevolution Medicines$17.1M15.70%83,133——-18.7%
▸ 4 NBPNovaBridge Biosciences$3.9M3.61%2,878,033——-37.7%
▸ 5 KURAKura Oncology$1.5M1.38%139,673——-27.5%
▸ 6 KRROKorro Bio$299.9K0.28%30,265——+28.3%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does AIHC Capital Management Ltd hold as of Q3 2026?

AIHC Capital Management Ltd reported 6 positions worth $108.7M in its Q3 2026 13F filing. Largest positions: ORIC (57.4%), LEGN (21.6%), RVMD (15.7%), NBP (3.6%) and KURA (1.4%).

What did AIHC Capital Management Ltd buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did AIHC Capital Management Ltd sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.